Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study

PURPOSE: Single-agent topotecan (TOPO) and combination topotecan and cyclophosphamide (TOPO/CTX) were compared in a phase II randomized trial in relapsed/refractory neuroblastoma. Because responders often underwent further therapies, novel statistical methods were required to compare the long-term o...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: London, Wendy B., Frantz, Christopher N., Campbell, Laura A., Seeger, Robert C., Brumback, Babette A., Cohn, Susan L., Matthay, Katherine K., Castleberry, Robert P., Diller, Lisa
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Clinical Oncology 2010
Предметы:
Original Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940398/
https://ncbi.nlm.nih.gov/pubmed/20660830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.27.5016
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы